Japanese drugmaker Eisai revealed that its in-house discovered tyrosine kinase inhibitor, Lenvima (lenvatinib mesylate), in combination with the anti-PD-1 antibody, pembrolizumab, and transarterial ...

TOKYO, July 25, 2025 - (JCN Newswire) - Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) announced today that it has been included in the FTSE4Good Index Series for the 24th ...

Stage 4 oesophageal cancer is an advanced form of the disease in which cancer has spread beyond the oesophagus to distant ...

AFTER an exhausting day’s travelling to Germany, Emma Bainbridge will this week take the next step in her international quest to beat the cancer that NHS doctors in the UK have told her is incurable.

Transarterial chemoembolization (TACE)—i.e., the delivery of chemotherapeutics directly into the vasculature of liver tumors—necessitates the use of guidewire-microcatheter systems to navigate ...

Study Rundown: Transarterial chemoembolization (TACE) is the standard treatment for patients with unresectable, non-metastatic hepatocellular carcinoma. However, current survival outcomes still leave ...

1. Progression-free survival was significantly greater in the lenvatinib plus pembrolizumab group compared to placebo. 2. Overall survival was higher in the intervention group, though not ...

Background: Although many studies reported the effectiveness of transarterial chemoembolization (TACE) combined with radiofrequency ablation (RFA) or surgical resection (SR) in the treatment of ...